The costs associated with the diagnosis and treatment of cancer in the UK will dramatically increase by 2021, according to a new report published by private healthcare provider Bupa.
The costs per year could rise to as much as £15.3bn, a 62% increase over the 2010 figure of £9.4bn.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The increases equate to an increase of approximately £10,000 to £40,000 for the average cost of treating someone diagnosed with cancer, representing a significant impact on the nation’s National Health Service.
The report was, however, dismissed by the Department of Health, which issued a statement reading: "Over the past five years, expenditure on cancer has grown no faster than costs for the NHS as a whole."
The report found that the NHS will be dealt the biggest impact, with costs rising by 65% to £5.2bn a year, with the private healthcare sector also witnessing a 65% increase to £531m a year.
Bupa expects demand for cancer diagnosis and treatment to rise by 2% annually over the next decade, with demand for new treatments to steadily rise by 3.7% a year over the same period.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataPotential approaches to reduce the impact highlighted by the report include improved national planning for the availability of new and innovative treatments, a rethink of how out-of-hospital care is managed, and enabling patients to transfer between public and private care facilities more easily.
